TB-500 (Thymosin Beta-4 fragment)
Muscle/RecoveryHealing / MobilityExperimental
Associated with actin modulation, cell migration, fibrosis modulation.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- —
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- 1–2× weekly or divided micro-doses
- Last updated
- 12/14/2025
- Targets
- Cytoskeleton/actin pathways
Overview
Associated with actin modulation, cell migration, fibrosis modulation.
Protocol
- Dosage Range
- 5–10 mg total per week (divided)
- Frequency
- 1–2× weekly or divided micro-doses
- Cycle
- 4–8+ weeks or as-needed maintenance
- Administration Route
- Subcutaneous
- Reconstitution Guide
- Add 2–5 mL bacteriostatic water per vial as preferred concentration.
Science
Mechanism of Action
Associated with actin modulation, cell migration, fibrosis modulation.
Targets
Cytoskeleton/actin pathways
Studies are being curated for this entry.
Suggest a studyBenefits
Mobility supportScar remodeling supportSoft-tissue recovery
Potential Side Effects
- Injection site irritation
- Headache (rare)
References
References coming soon.
Suggest a reference